2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors

NCT00030095 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: 2-methoxyestradiol

Sponsor

National Cancer Institute (NCI)